AstraZeneca inks China AI research deal for chronic diseases

Medical and Hospital News

AstraZeneca inks China AI research deal for chronic diseases

AstraZeneca inks China AI research deal for chronic diseases
by AFP Staff Writers
London (AFP) June 13, 2025

British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC Pharmaceuticals worth up to $5.3 billion to tackle chronic diseases.

AstraZeneca, which has a pre-existing collaboration with CSPC, announced earlier this year plans to invest $2.5 billion in China.

"This strategic research collaboration underscores our commitment to innovation to tackle chronic diseases which impact over two billion people globally," said AstraZeneca executive vice president Sharon Barr.

AstraZeneca aims to develop a research and development centre of up to 1,700 people in the country.

CSPC will carry out the research in Shijiazhuang, using "their AI-driven, dual-engine efficient drug discovery platform", the firm said.

AstraZeneca said the agreement will see CSPC receive an upfront payment of $110 million, plus up to $1.62 billion in "potential development milestone payments" and up to a further $3.6 billion in sales milestone payments, along with annual sales-based royalties.

The multinational will also be able to exercise options for exclusive licences to develop and commercialise worldwide candidates identified under the deal.

ode/zap/cw/djt/lth

ASTRAZENECA

Related Links
Hospital and Medical News at InternDaily.com

Subscribe Free To Our Daily Newsletters

RELATED CONTENT

The following news reports may link to other Space Media Network websites.

Regeneron to buy 23andMe out of bankruptcy for $256 mn
New York (AFP) May 19, 2025
Regeneron Pharmaceuticals said Monday it will buy genetic testing company 23andMe out of bankruptcy for $256 million, a deal that provides the US biotech company with data on millions of clients. New York-based Regeneron said it had been named the successful bidder in the bankruptcy auction for 23andMe, which has struggled with falling sales following a 2023 data breach that saw nearly seven million accounts affected. Regeneron CEO George Yancopoulos described his enterprise as "a science-driven ... read more

Satellite expands Chinas disaster warning network through global electromagnetic monitoring

UK nuclear site could leak until 2050s, MPs warn

Israel to expel French nationals on Gaza aid boat by end of week

Trump deploys Marines as tensions rise over Los Angeles protests

SpaceX launches advanced GPS satellite for Space Force

Satellites Enhance Navigation Safety on the Mersey with Cutting-Edge Tidal Mapping

Sierra Space Reaches Key Milestone in Space Force R-GPS Program

Children as young as five can navigate a 'tiny town'

Light travels through entire human head in breakthrough for optical brain imaging

Human brain reveals hidden action cues AI still fails to grasp

If people stopped having babies, how long would it be before humans were all gone?

Overlooked cells might explain the human brain's huge storage capacity

Tiny organisms, huge implications for people

Scientists track egret's 38-hour flight from Australia to PNG

Hiker dies in Greece bear encounter

Monkey business delays Sri Lanka's wildlife survey

After quitting WHO, US urges others to 'consider joining us': Kennedy

Dengue, chikungunya may soon be endemic in Europe: research

White House site blames China for Covid-19 'lab leak'

Pentagon invites back former military fired for refusing COVID-19 vaccines

Chinese man defies demolition orders to build madcap rural home

Consciousness and collaboration in the astronomy archives of premodern China

Millions sit China's high-stakes university entrance exam

Beijing slams Rubio 'attack' on China after Tiananmen Square remarks

Blast kills six soldiers in Mexican cartel zone

Trump attends memecoin gala as protesters slam 'crypto corruption'

U.S. blacklists two alleged high-ranking Cartel del Noreste members

Trump hosts gala for memecoin buyers despite corruption concerns

Subscribe Free To Our Daily Newsletters

The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.